About Valary Lab

Leading API Manufacturer with a Focus on Quality and Innovation

Valary Lab Private Limited, established in 2019, operates a cutting-edge pharmaceutical facility in Andhra Pradesh, India. Specializing in Containment Active Pharmaceutical Ingredients (APIs), we focus on oncology and hormone therapies, adhering to cGMP standards for safety and quality

Key Facility Features:

Prime Location

26 km from Visakhapatnam Airport, 15 km from Duvvada Railway Station

Expansive Infrastructure

9,773 sq. meters with 2,896 sq. meters built-up area for production, QC, and warehousing.

Icon Inside Circle
Product Focus

Oncology and Hormone APIs with ISO 8/Class 100000 cleanrooms for product safety.

Our Quality Commitment

Uncompromising Focus on Quality and Compliance

At Valary Lab, we uphold stringent quality systems to meet global regulatory standards and customer expectations, ensuring the highest levels of product safety and efficacy

Our Quality Approach :

Global Compliance: Approved by regulatory bodies, including the US FDA and Hungary's Directorate for Drug Inspection.

Quality Systems:
Comprehensive QA/QC procedures adhering to international guidelines.

Products and Capabilities

Advanced Oncology and Hormone API Manufacturing

Valary Lab focuses on high-containment API manufacturing for oncology and hormone therapies. Our facility includes two
production blocks and six lines handling multiple oncology products simultaneously.

Key
Oncology
Products

Cyclophosphamide, Capecitabine, Ribociclib Succinate, Lenalidomide and Niraparib Tosylate

Hormone
Product
Expertise

Separate lines for hormones like Ethinyl Estradiol, Levothyroxine Sodium and Liothyronine Sodium, with containment at OEB 4 and 5 levels.

Disclaimer: The products covered under valid and enforceable patents in India or elsewhere, will be supplied solely for the Research & Development purposes, and submission of information required by Regulatory Agencies in India or elsewhere, according to the section 107A of the Indian Patent Act, 1970. Buyers will be solely responsible for any liability associated with the infringement of patents, in their respective markets.

Regulatory Approvals

Global Regulatory Compliance – Your Assurance of Excellence

Valary Lab operates under a robust regulatory framework, passing inspections from global health authorities.

US FDA

August 2022, September 2024

Hungary’s National Center for Public Health and Pharmacy:

April 2024

State-of-the-Art Facility

Modern Manufacturing
Facility Built for
Precision and Scale

Our facility is equipped with advanced technology, including stainless steel reactors, glass-lined reactors, and HEPA-filtered cleanrooms, ensuring precision at every step.

Key Features

ISO 8/Class 100000 cleanrooms,
high-capacity reactors,
and crystallization equipment.

Sustainability and EHS

Commitment to Environmental Health and Safety

Valary Lab adheres to strict EHS standards, with certified waste management systems and comprehensive safety protocols in place to ensure sustainable operations.

Key Initiatives :

Effluent Treatment: Managed via certified pipeline transfer to treatment facilities.

Safety Systems
Fire hydrants and environmental protection protocols

Our People

A Dedicated Team Driving
Excellence 24/7

Our success is powered by 200+ skilled professionals working
round-the-clock. Continuous employee development through
rigorous training ensures technical and leadership excellence.